Skip to main content
. 2015 Nov 26;139(1):23–30. doi: 10.1093/brain/awv326

graphic file with name awv326fig1g.jpg

The presence of β-amyloid in the brain may represent a preclinical stage of Alzheimer’s disease, but this is controversial. Jagust examines the association between β-amyloid and biomarkers of Alzheimer’s disease in cognitively normal older people, concluding that β-amyloid is harmful to the brain in a manner consistent with Alzheimer’s disease.